Thermo Fisher Scientific (TMO) Non-Current Assets (2009 - 2026)

Thermo Fisher Scientific has reported Non-Current Assets for 18 years, with the latest figure at $89.8 billion in Q2 2026.

• Non-Current Assets for Q2 2026 came in at $89.8 billion, up 17.17% year-over-year; the trailing twelve-month figure through Jun 2026 was $343.1 billion (up 12.85% YoY), and the FY2025 annual result was $81.6 billion, up 8.58% from the prior year.
• Non-Current Assets declined to $89.8 billion in Q2 2026, from $91.0 billion in the prior quarter.
• Over five years, Non-Current Assets peaked at $91.0 billion in Q1 2026 and troughed at $71.2 billion in Q4 2022.
• A 5-year average of $76.7 billion and a median of $74.3 billion in 2023 frame the typical range for Non-Current Assets.
• The largest YoY upside for Non-Current Assets was 53.32% in 2022 against a maximum downside of 4.11% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $71.9 billion in 2022, then gained by 3.08% to $74.1 billion in 2023, then climbed by 1.41% to $75.2 billion in 2024, then climbed by 8.58% to $81.6 billion in 2025, then climbed by 10.01% to $89.8 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $89.8 billion in Q2 2026, $91.0 billion in Q1 2026, and $81.6 billion in Q4 2025.